Responding to media speculation, Specialty pharmaceutical company Warner Chilcott plc (WCRX) confirmed Monday that it is conducting a process to explore a broad range of strategic alternatives to enhance shareholder value, which include preliminary discussions with potential offerors.
Warner Chilcott stated that those discussions are at a preliminary stage and may or may not lead to an offer for the company.
The company said it does not intend to disclose further developments regarding the process unless and until its Board has approved a specific course of action, or it otherwise deems further disclosure is appropriate or required.
For comments and feedback: editorial@rttnews.com